Stock Events

Stock Events

Aclaris Therapeutics (ACRS) Q4 2023 Earnings

27FebConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.48

-0.42

-0.36

-0.3

Details

Expected EPS

-0.34

Actual EPS

-0.3

Surprise EPS

0.04

Surprise Percent

+11.76%

Description

Aclaris Therapeutics (ACRS) has reported earnings of -0.3 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.